Metabolon Enters Into Collaboration Agreement With Human Longevity Inc. To Provide Metabolomic Profiling Services

RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--Metabolon, Inc., the world’s leading commercial-stage metabolomics company, announces the signing of an agreement with newly-launched Human Longevity Inc. (HLI), whereby Metabolon will provide biochemical profiling services to assist HLI in its mission to tackle diseases of aging by building the world’s largest and most complete human genotype, microbiome and phenotype database. In the initial term of the agreement Metabolon will carry out small molecule analysis of 10,000 subjects and collaborate with HLI to map changes in the small molecules to end points of disease and gene mutations.

Help employers find you! Check out all the jobs and post your resume.